Subscribe
gavel-istock-508411976_andreypopov
AndreyPopov / iStockphoto.com
5 December 2018Americas

GE Healthcare files patent lawsuit against Bio-Rad

American conglomerate GE Healthcare (GE) last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.


Editor's picks

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

Editor's picks

Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025

More on this story

Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.

More on this story

Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.

More features

South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
In vivo cell therapy: A world beyond ex vivo engineering
Patent litigator with biotech and medical device background joins Sterlington
Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency
Fenwick establishes new Boston office with trio of IP partners from Cooley
How pharma should prep for the six-bill avalanche from Congress
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
USPTO speeds up patent issuance amid widespread agency changes